10/06/2020 – RespireRx Pharmaceuticals Inc. Announces Publication of Preclinical Results Supporting the Use of Ampakines in the Treatment of Spinal Cord Injury October 6, 2020j3ff1
09/25/2020 – RespireRx Pharmaceuticals Inc. Announces Appointment of David Dickason as Senior Vice President Pre-Clinical Product Development September 25, 2020j3ff1
08/04/2020 – CEO of RespireRX Pharmaceuticals Inc., Tim Jones, is Featured on The Stock Day Podcast August 17, 2020j3ff1
